The higher prescription of insulin analogs in T1DM aligns with Brazilian Diabetes Society guidelines, recommending long-acting and short-acting analogs for better glycemic control and reduced hypoglycemia events [26]. This evidence concerns the gene INS and diabetes mellitus.